All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AR1001Phase 31 trial

    AriBio Co., Ltd. · Alzheimer Disease

  • arboplatinPhase 31 trial

    Hansoh BioMedical R&D Company · Platinum-sensitive Recurrent Ovarian Cancer

  • ASI-02Phase 31 trial

    Agitated Solutions, Inc. · Right-To-Left Shunt

  • ASP2138Phase 31 trial

    Astellas · Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma

  • ASTX030cedazuridine + azacitidinePhase 31 trial

    Taiho Oncology, Inc. · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm

  • ATB-1011Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1012Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1013Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma

  • Atigotatug+NivolumabBMS-986489Phase 31 trial

    Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer

  • ATSN-201Phase 31 trial

    Atsena Therapeutics Inc. · X-linked Retinoschisis

  • Avexitideexendin 9-39Phase 31 trial

    Amylyx Pharmaceuticals Inc. · Post Bariatric Hypoglycemia

  • AVT29proposed aflibercept HD biosimilarPhase 31 trial

    Alvotech Swiss AG · Diabetic Macular Edema

  • AXS-07meloxicam-rizatriptanPhase 31 trial

    Axsome Therapeutics, Inc. · Migraine

  • B001Phase 31 trial

    Shanghai Jiaolian Drug Research and Development Co., Ltd · Neuromyelitis Optica Spectrum Disorders

  • B2227Phase 31 trial

    Bostal Drug Delivery Co., Ltd · Schizophrenia

  • BAT1706Phase 31 trial

    BeOne Medicines (BeiGene) · Advanced Malignancies

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • BCD-281Phase 31 trial

    Biocad · Relapsing-remitting Multiple Sclerosis (RRMS)

  • BE11164F-PCCPhase 31 trial

    CSL Behring · Complex Cardiovascular Surgery With Cardiopulmonary Bypass

  • BecavizumabPhase 31 trial

    Roche (Genentech) · Hepatocellular Carcinoma

  • BemarituzumabPhase 31 trial

    Amgen · Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • bemdaneprocelMSK-DA01, BRT-DA01Phase 31 trial

    BlueRock Therapeutics · Parkinsons Disease (PD)

  • BERLIM 2520 ASSOCIATIONPhase 31 trial

    EMS · Dyslipidemia Associated With Type II Diabetes Mellitus

  • BGB-43395Phase 31 trial

    BeOne Medicines (BeiGene) · HR+/HER2- Breast Cancer

  • BHV-1400Phase 31 trial

    Biohaven Therapeutics Ltd. · IgA Nephropathy

  • BHV-8000Phase 31 trial

    Biohaven Therapeutics Ltd. · Parkinson Disease

  • BK1803Phase 31 trial

    Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus

  • BLI5100Phase 31 trial

    Braintree Laboratories · Erosive Esophagitis

  • Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis

  • BMN 333Phase 31 trial

    BioMarin · Achondroplasia

  • BMS-663068Phase 31 trial

    GSK · HIV Infections

  • BMS-986365Phase 31 trial

    Bristol Myers Squibb · Metastatic Castration-resistant Prostate Cancer

  • BNC210Phase 31 trial

    Bionomics Limited · Social Anxiety Disorder

  • BNT113Phase 31 trial

    BioNTech SE · Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer

  • BR1018APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1018C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Primary Hypercholesterolemia

  • BR1019APhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019BPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019CPhase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BRC-201TG-1000, Pixavir MarboxilPhase 31 trial

    Boryung Biopharma Co., Ltd. · Influenza

  • Buparlisib & PaclitaxelAN2025Phase 31 trial

    Adlai Nortye Biopharma Co., Ltd. · Head and Neck Cancer

  • CSPC Ouyi Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)

NewerPage 21 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.